188 related articles for article (PubMed ID: 31977480)
1. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
Lim CH; Park YJ; Shin M; Cho YS; Choi JY; Lee KH; Hyun SH
Clin Nucl Med; 2020 Mar; 45(3):e128-e133. PubMed ID: 31977480
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
3. FDG PET using SUV
Huang YC; Lu HI; Huang SC; Hsu CC; Chiu NT; Wang YM; Chiu YC; Li SH
BMC Med Imaging; 2017 Jan; 17(1):1. PubMed ID: 28056868
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Clinicopathological Characteristics and PET/CT Uptake in Esophageal Squamous Cell Carcinoma: [
Dong Y; Wei Y; Chen G; Huang Y; Song P; Liu S; Zheng J; Cheng M; Yuan S
Mol Imaging Biol; 2019 Feb; 21(1):175-182. PubMed ID: 29869060
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
[TBL] [Abstract][Full Text] [Related]
7. Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study.
Miyawaki Y; Sato H; Fujiwara N; Oya S; Sugita H; Hirano Y; Yamane T; Sakuramoto S; Okamoto K; Yamaguchi S; Koyama I
Int J Clin Oncol; 2020 Apr; 25(4):561-569. PubMed ID: 31867680
[TBL] [Abstract][Full Text] [Related]
8. Use of
Iqbal SA; Goel S; Aggarwal A; Gupta N; Gupta M; Durga G; Talwar V; Singh S
J Gastrointest Cancer; 2021 Sep; 52(3):1073-1080. PubMed ID: 33128717
[TBL] [Abstract][Full Text] [Related]
9. Association between prognosis and lymph node status using
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
World J Surg; 2024 Mar; 48(3):650-661. PubMed ID: 38686781
[TBL] [Abstract][Full Text] [Related]
10. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy.
Hamai Y; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Furukawa T; Kurokawa T; Ohsawa M; Yoshikawa T; Okada M
Ann Surg Oncol; 2020 Oct; 27(11):4422-4430. PubMed ID: 32405978
[TBL] [Abstract][Full Text] [Related]
11. The role of
Wang X; Yang W; Zhou Q; Luo H; Chen W; Yeung SJ; Zhang S; Gan Y; Zeng B; Liu Z; Feng S; Zhang X; Cheng C
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4241-4251. PubMed ID: 35732974
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.
Chen PJ; Yap WK; Chang YC; Tseng CK; Chao YK; Hsieh JC; Pai PC; Lee CH; Yang CK; Ho AT; Hung TM
BMC Cancer; 2020 Jun; 20(1):545. PubMed ID: 32522275
[TBL] [Abstract][Full Text] [Related]
13. Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.
Ela Bella AJ; Zhang YR; Fan W; Luo KJ; Rong TH; Lin P; Yang H; Fu JH
Chin J Cancer; 2014 Apr; 33(4):211-7. PubMed ID: 24559853
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma.
Toriyama K; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Mizuno N; Kuwahara T; Okuno N; Matsumoto S; Sasaki E; Abe T; Yatabe Y; Hara K; Matsuo K; Tamaki T; Niwa Y
World J Gastroenterol; 2019 Dec; 25(46):6767-6780. PubMed ID: 31857778
[TBL] [Abstract][Full Text] [Related]
15. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
[TBL] [Abstract][Full Text] [Related]
16. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of venous invasion and maximum standardized uptake value of
Jeon JH; Lee JM; Moon DH; Yang HC; Kim MS; Lee GK; Zo JI
Eur J Surg Oncol; 2017 Feb; 43(2):471-477. PubMed ID: 27912930
[TBL] [Abstract][Full Text] [Related]
18. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.
Hamai Y; Hihara J; Emi M; Furukawa T; Yamakita I; Kurokawa T; Okada M
Ann Thorac Surg; 2016 Oct; 102(4):1132-9. PubMed ID: 27319990
[TBL] [Abstract][Full Text] [Related]
19. Role of
Sasaki K; Uchikado Y; Okumura H; Omoto I; Kita Y; Arigami T; Uenosono Y; Owaki T; Maemura K; Natsugoe S
Anticancer Res; 2017 Feb; 37(2):859-864. PubMed ID: 28179343
[TBL] [Abstract][Full Text] [Related]
20. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]